Aspirin desensitization for aspirin‐exacerbated respiratory disease in the era of biologics: Clinical perspective

Saved in:
Bibliographic Details
Published inInternational forum of allergy & rhinology Vol. 11; no. 4; pp. 822 - 823
Main Author Bosso, John V.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.04.2021
Subjects
Aspirin
Respiratory diseases
Online AccessGet full text

Cover

More Information
Bibliography:Conflict of interest: J.V.B. has served on the scientific advisory boards for Glaxo SmithKline, Sanofi, Regeneron, Novartis, Optinose, and Astra‐Zeneca.
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:2042-6976
2042-6984
DOI:10.1002/alr.22709